Irinotecan Hydrochloride and Omalizumab Subcutaneous
Determining the interaction of Irinotecan Hydrochloride and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: irinotecan
Brand name: Camptosar
Synonyms: Irinotecan (Conventional), Irinotecan
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Irinotecan Hydrochloride-Ombitasvir, Paritaprevir, and Ritonavir
- Irinotecan Hydrochloride-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Irinotecan Hydrochloride-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Irinotecan Hydrochloride-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Irinotecan Hydrochloride-Omeclamox-Pak
- Irinotecan Hydrochloride-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Irinotecan Intravenous
- Omalizumab Subcutaneous-Irinotecan liposomal
- Omalizumab Subcutaneous-Irinotecan liposome Intravenous
- Omalizumab Subcutaneous-Iron 100/C
- Omalizumab Subcutaneous-Iron 21/7
- Omalizumab Subcutaneous-Iron and Docusate